Ironwood Capital Connecticut Announces Air Temp Mechanical Services, Inc. Exit

By on , Announcements

AVON, CONNECTICUT, February 10, 2020 – Ironwood Capital Connecticut, a unit of Ironwood Capital, is pleased to announce an exit from a subordinated debt investment in Air Temp Mechanical Services, Inc. (“Air Temp”), made by its co-managed fund. The fund maintains its warrant position in Air Temp, headquartered in Southington, Connecticut. Air Temp is a […]

Patrick Patrell Joins Ironwood Capital as Analyst

By on , Announcements

AVON, CONNECTICUT, January 23, 2020 – Ironwood Capital is pleased to announce Patrick Patrell has joined the firm as an analyst. Patrick will be working on the firm’s Connecticut-focused investment activities.  He is responsible for reviewing new investment opportunities, conducting research,  performing financial modeling and due diligence, and ongoing portfolio management. Noted Carolyn Galiette, president […]

Merrill Industries LLC, Ironwood Capital Connecticut Portfolio Company, in the News

By on , In the News

Ironwood Capital Connecticut portfolio company Merrill Industries LLC was recently featured in Boxscore, a publication of the Independent Packaging Association. Merrill Industries is a niche manufacturer of innovative packaging solutions.  Rick Wheeler, Merrill CEO, was interviewed for the article.  In the article, Wheeler summarized what it takes to succeed when rebranding your company,”‘I just can’t […]

P2 Science, Ironwood Capital Connecticut Portfolio Company, Opens Green Chemistry Plant in Naugatuck

By on , In the News

REPRINTED from Global Cosmetic Industry, September 13, 2018 Biorenewable chemistry company P2 Science Inc. has celebrated the opening of its latest Naugatuck, Connecticut facility with a ribbon-cutting ceremony. With commercial production starting in October, the green chemistry advanced manufacturing plant will focus on creating renewable intermediates and ingredients for the fragrances, flavors and cosmetics industry. […]

Ironwood Capital Connecticut Portfolio Company IsoPlexis: Response noted in non-Hodgkin patients

By on , In the News

Reprinted from BioCT, June 22, 2018 IsoPlexis has announced the publication of clinical data demonstrating a significant association between the functionality of anti-CD19 CAR-T cell product before treatment, as defined by IsoPlexis’ Polyfunctional Strength Index (PSI), and the objective response in patients with non-Hodgkin lymphoma. “We were excited to collaborate on this groundbreaking research,” said […]

Ironwood Capital Connecticut Announces Additional Investment in Merrill Industries

By on , Announcements

AVON, CONNECTICUT, January 20, 2017 – Ironwood Capital Connecticut (“ICC”), a unit of Ironwood Capital, is pleased to announce a subordinated debt and equity recapitalization of Merrill Industries. Merrill is based in Ellington, Connecticut and designs and manufactures customized packaging products for a wide range of clients. This and a prior investment in Merrill were […]

Ironwood Capital Connecticut Announces Investment in IsoPlexis

By on , Announcements

AVON, CONNECTICUT, November 28, 2016 – Ironwood Capital Connecticut, a unit of Ironwood Capital, is pleased to announce an investment in IsoPlexis, a venture capital funded life sciences company developing a diagnostic platform to measure cellular immune response in patients. “IsoPlexis has developed a broad platform with enormous potential to advance personalized medicine and has […]

Ironwood Capital Connecticut Announces Investment in Polder Products

By on , Announcements

AVON, CONNECTICUT, January 19, 2016 – Ironwood Capital Connecticut, a unit of Ironwood Capital, is pleased to announce an investment in Polder Housewares. Investment proceeds were used to support the acquisition of Polder by Topspin Partners of Mamaroneck, New York. “Polder has a long and strong history in Connecticut and is a great fit for […]

Congratulations to New Haven Pharmaceuticals’ Patrick Fourteau – CURE Entrepreneur of the Year Awards

By on , Ironwood Insights

We are delighted to see that Patrick Fourteau, president and CEO of New Haven Pharmaceuticals, Inc. (New Haven Pharma), has been named one of two winners of the CURE Entrepreneur of the Year Award and was recognized at a ceremony on December 8 in New Haven. CURE is the Connecticut bioscience organization. The CURE Entrepreneur […]

Ironwood Capital Connecticut Announces Exit of Investment in AxioMx Through a Sale to Abcam plc

By on , Announcements

AVON, CONNECTICUT, December 1, 2015 –  Ironwood Capital Connecticut, a unit of Ironwood Capital, is pleased to announce the exit of an investment in AxioMx, Inc. through a sale of the company to Abcam plc, a global leader in the supply of life science research tools.  Abcam is headquartered in Cambridge, United Kingdom.  The purchase price was $20 […]